Literature DB >> 19021227

Geographical difference in Parkinson's disease prevalence within West Scotland.

Edward J Newman1, Katherine A Grosset, Donald G Grosset.   

Abstract

The wide range in reported prevalence of Parkinson's disease (PD) in the United Kingdom (between 108 and 164 per 100,000) is usually attributed to differences in study methodology. We report prevalence of PD in four geographic areas within West Scotland, which was calculated using the same methodology, from prescription database searches within primary care, combined with full case record review. Crude prevalence was 119.2 per 100,000 (95% CI 109.7-128.6) and age-adjusted prevalence was 129.5 (95% CI 119.6-139.4) in 92 General Practices covering a population of 511,927. Prevalence was significantly lower in South Glasgow (men 98.3, CI 78.7-117.9; women 83.9, CI 65.6-102.2) than South Lanarkshire (men 202.7, CI 175.0-230.4; women 151.1, CI 127.7-174.5), age-adjusted rates, both P < 0.001. Factors associated with higher prevalence of PD, such as lower cigarette smoking rates, higher education level, and rural living, were higher in South Lanarkshire than South Glasgow, but the magnitude of the difference was greater than expected considering studies describing relative risk for these factors. Access to services, and specialist clinic attendance were both higher for South Glasgow, which may influence diagnostic accuracy, time to diagnosis, and time to initiating antiparkinson therapy. Exploration of these factors is justified to explain further such wide variation in PD prevalence. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19021227     DOI: 10.1002/mds.22359

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  The health-related, social, and economic consequences of parkinsonism: a controlled national study.

Authors:  Poul Jennum; Marielle Zoetmulder; Lise Korbo; Jakob Kjellberg
Journal:  J Neurol       Date:  2011-03-11       Impact factor: 4.849

2.  Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

Authors:  Allison Wright Willis; Bradley A Evanoff; Min Lian; Susan R Criswell; Brad A Racette
Journal:  Neuroepidemiology       Date:  2010-01-15       Impact factor: 3.282

3.  The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease.

Authors:  Simon Eggington; Francesc Valldeoriola; K Ray Chaudhuri; Keyoumars Ashkan; Elena Annoni; Günther Deuschl
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

4.  Prevalence of Advanced Parkinson's Disease in Patients Treated in the Hospitals of the Spanish National Healthcare System: The PARADISE Study.

Authors:  Juan Carlos Martínez-Castrillo; Pablo Martínez-Martín; Ángel Burgos; Gloria Arroyo; Natalia García; María Rosario Luquín; José Matías Arbelo
Journal:  Brain Sci       Date:  2021-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.